UV TRANSILLUMINATOR AND CHEMILUMINESCENE INAGING SYSTEM TRA

The National Institutes of Health, through the National Institute of Diabetes and Digestive and Kidney Diseases, is seeking a replacement ultraviolet transilluminator and chemiluminescence imaging system to restore critical laboratory functionality for the Liver Diseases Branch. The current system has failed and cannot be repaired, and its absence is impeding ongoing research into liver diseases and viral infections by preventing the visualization and documentation of biological samples essential for analyzing experimental outcomes. This equipment is vital to federally funded studies aimed at understanding viral mechanisms and identifying potential therapeutic interventions, and without it, research progress will be significantly delayed. The requirement is tied directly to the branch’s mission to advance biomedical knowledge in liver health. The solicitation, identified as 75N98026Q00891AZUREBIOSYSTEMS, was posted on July 28, 2026, with a response deadline of August 6, 2026, and is categorized as a presolicitation with no set-aside designation. The NAICS code 339999 identifies it under miscellaneous manufacturing, and the contract will be awarded to support work performed at the NIH campus in Bethesda, Maryland. The primary point of contact for inquiries is Vishnuvajjala Hanumanth Rao, reachable via email at vishnuh@mail.nih.gov, and the procurement falls under the Department of Health and Human Services. The acquisition aims to procure a single integrated system capable of meeting the specific imaging needs of the laboratory, ensuring continuity in high-priority scientific investigations.